Opinion|Videos|February 10, 2025
Navigating New Treatment Options for Pediatric Atopic Dermatitis Management
Panelists discuss the role of newer agents, including biologics/monoclonal antibodies (dupilumab, tralokinumab, lebrikizumab) and Janus kinase (JAK) inhibitors (abrocitinib, baricitinib, upadacitinib), in the treatment of moderate to severe atopic dermatitis, emphasizing their effectiveness in improving outcomes for patients who do not have adequate control with conventional therapies.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- Where do you see the newer agents fitting into moderate to severe atopic dermatitis treatment?
- Biologics/monoclonal antibodies: dupilumab, tralokinumab, lebrikizumab
- JAK inhibitors: abrocitinib, baricitinib, upadacitinib
Advertisement
Related to this article
Johns Hopkins Children's Center experts outline pedestrian, burn, allergy, anxiety, and candy guidance pediatricians can share before Halloween.
Pumpkin carving accounts for 55% of Halloween ED injuries; AAOS outlines prevention tips for carving, costumes, and trick-or-treating.
NHIS data show the share of US children aged 5 to 17 years ever diagnosed with ADHD climbed from 9.9% in 2019 to 13.8% in 2025.
A proposed rule would revise iodine, manganese, and vitamin A and D levels in infant formula and reaffirm 4 other nutrient specifications.
A review of 93 studies links pediatric home-based hospice and palliative care to fewer hospital days, lower costs, and better family QOL.
With California WNV activity at a 5-year high, CHLA outlines age-based repellent and bite-prevention guidance for children.
Missed the AAP's new congenital measles guidance? This easy-to-read FAQ covers what pediatric clinicians need to know.
Self-harm risk in ADHD peaked in the 90 days before medication initiation and declined once treatment began, a 5-system analysis found.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FAQ: What should clinicians know about congenital measles?
2
CDC: ADHD diagnoses in US children rose to 13.8% from 2019 to 2025
3
Pumpkin carving drives over half of Halloween ED injuries
4
Experts share pediatric Halloween safety guidance
5